Biblio

Author Title [ Type

] Year

Filters: First Letter Of Title is W [Clear All Filters]

Journal Article

Suzuki S, Diaz VD, Hermann BP. What has single-cell RNA-seq taught us about mammalian spermatogenesis?. Biol Reprod. 2019.

Korrapolu RSharon Ang, Boddu D, John R, Antonisamy N, Geevar T, Arunachalam AKumar, Joseph LLizbeth, Srinivasan HNalapullu, Mathew LGrace, Totadri S. What happens to children with acute lymphoblastic leukemia in low- and middle-income countries after relapse? A single-center experience from India. Pediatr Hematol Oncol. 2023:1-10.

Tischler AS. What happens in "chromospheres"?. Stem Cells Transl Med. 2013;2(12):1020.

Orlova VV, Mummery CL. What Endothelial Cells from Patient iPSCs Can Tell Us about Aortic Valve Disease. Cell Stem Cell. 2015;16(5):455-457.

Peters F, Wickström SA. What doesn't kill you makes you differentiate. Dev Cell. 2021;56(24):3303-3304.

Qureshi-Baig K, Ullmann P, Rodriguez F, Frasquilho S, Nazarov PV, Haan S, Letellier E. What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue. PLoS One. 2016;11(1):e0146052.

Barata A, Abrams HR, Meyer CL, Mau L-W, Mattila D, Burns LJ, Ullrich CK, Murthy HS, Wood WA, Petersdorf EW, et al. What Do Patients Think about Palliative Care? A National Survey of Hematopoietic Stem Cell Transplant Recipients. Blood Adv. 2023.

Chen K, Zhu P, Chu M, Tao H, Wang Q, Lv S, Huang L, Geng D. What do osteoporosis and osteoarthritis have in common？An integrated study of overlapping differentially expressed genes in bone mesenchymal stem cells of osteoporosis and osteoarthritis. Gene. 2023:147914.

Dorison A, Forbes TA, Little MH. What can we learn from kidney organoids?. Kidney Int. 2022.

Broeckel U. What Can hiPSC-Cardiomyocytes Teach Us about Modeling Complex Human Disease Phenotypes?. Cell Stem Cell. 2016;19(3):282-284.

Pellman BA, Kim JJ. What Can Ethobehavioral Studies Tell Us about the Brain's Fear System?. Trends Neurosci. 2016.

Chandhanayingyong C, Thanapipatsiri P, Pairojboriboon S, Luenam S, Hongsaprabhas C, Charoenlap C, Wattanapaiboon K, Asavamongkolkul A, Tharmviboonsri T, Phimolsarnti R. What Are the MSTS Scores and Complications Associated With the Use of Three-dimensional Printed, Custom-made Prostheses in Patients Who Had Resection of Tumors of the Hand and Foot?. Clin Orthop Relat Res. 2023.

Lalu MM, Foster M, Presseau J, Dowlatshahi D, Castillo G, Cardenas A, Tam W, Zlepnig J, Timpson D, Dong YYi, et al. What are potential barriers and enablers to patient and physician participation in Canadian cell therapy trials for stroke? A stakeholder interview study. BMJ Open. 2020;10(3):e034354.

Cytryn R, Bickell N, Yagnik R, Jagannath S, Lin JJ. What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study. Cancers (Basel). 2023;15(8).

Mudde ACa, Kuo CY, Kohn DB, Booth C. What a Clinician Needs to Know about Genome Editing: Status and Opportunities for Inborn Errors of Immunity. J Allergy Clin Immunol Pract. 2024.

Anon. Wharton's Jelly-Mesenchymal Stem Cell-Engineered Conduit for Pediatric Translation in Heart Defect, by Iacobazzi, et al. Tissue Engineering Part A 2021;27(3-4):201-213; doi: 10.1089/ten.tea.2020.0088. Tissue Eng Part A. 2023.

Pochon C, Notarantonio A-B, Laroye C, Reppel L, Bensoussan D, Bertrand A, Rubio M-T, D'Aveni M. Wharton's jelly-derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation. J Cell Mol Med. 2022.

Penolazzi L, Chierici A, Notarangelo MPina, Dallan B, Lisignoli G, Lambertini E, Greco P, Piva R, Nastruzzi C. Wharton's jelly-derived multifunctional hydrogels: New tools to promote intervertebral disc regeneration in vitro and ex vivo. J Biomed Mater Res A. 2024.

Cheng T, Yang B, Li D, Ma S, Tian Y, Qu R, Zhang W, Zhang Y, Hu K, Guan F, et al. Wharton's Jelly Transplantation Improves Neurologic Function in a Rat Model of Traumatic Brain Injury. Cell Mol Neurobiol. 2015.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, et al. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation. Regen Med. 2014;9(6):723-732.

Mokhtari T, Shayan M, Rashnudi ARezaei, Hassanzadeh G, Nia KMehran. Wharton's jelly mesenchymal stem cells attenuate global hypoxia-induced learning and memory impairment via preventing blood-brain barrier breakdown. Iran J Basic Med Sci. 2023;26(9):1053-1060.

Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun AAl. Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. Front Cell Dev Biol. 2023;11:1211217.

Varaa N, Azandeh S, Khodabandeh Z, Gharravi AMohammad. Wharton's Jelly Mesenchymal Stem Cell: Various Protocols for Isolation and Differentiation of Hepatocyte-Like Cells; Narrative Review. Iran J Med Sci. 2019;44(6):437-448.

Kalaszczynska I, Ferdyn K. Wharton's Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance. Biomed Res Int. 2015;2015:430847.

Aratikatla A, Maffulli N, Gupta M, Potti IA, Potty AG, Gupta A. Wharton's jelly and osteoarthritis of the knee. Br Med Bull. 2023.

Pages